Addressing phenoconversion: the Achilles' heel of personalized medicine
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Addressing phenoconversion: the Achilles' heel of personalized medicine
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 79, Issue 2, Pages 222-240
Publisher
Wiley
Online
2014-06-10
DOI
10.1111/bcp.12441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP2D6 genotyping and tamoxifen in the treatment of post-menopausal breast cancer - a reply
- (2014) Hiltrud Brauch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Challenges in CYP2D6 Phenotype Assignment from Genotype Data: A Critical Assessment and Call for Standardization
- (2014) J. Hicks et al. CURRENT DRUG METABOLISM
- Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
- (2014) Ralph-Steven Wedemeyer et al. DRUG SAFETY
- Role of brain cytochrome P450 (CYP2D) in the metabolism of monoaminergic neurotransmitters
- (2014) Anna Haduch et al. Pharmacological Reports
- No association found betweenCYP2D6genotype and early breast cancer events in tamoxifen-treated patients
- (2013) Andrea Markkula et al. ACTA ONCOLOGICA
- Hospitalization for Hemorrhage Among Warfarin Recipients Prescribed Amiodarone
- (2013) Jason Lam et al. AMERICAN JOURNAL OF CARDIOLOGY
- Prediction of tamoxifen outcome by genetic variation of CYP2D6 in post-menopausal women with early breast cancer
- (2013) Hiltrud Brauch et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2D6 polymorphisms influence tamoxifen treatment outcomes in breast cancer patients: a meta-analysis
- (2013) Zhiyu Zeng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CYP2D6 Genotype and Tamoxifen Activity: Understanding Interstudy Variability in Methodological Quality
- (2013) M J Ratain et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Genetics, Epigenetics, and Regulation of Drug-Metabolizing Cytochrome P450 Enzymes
- (2013) U M Zanger et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The (R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers
- (2013) Satoshi Yamada et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- The endogenous substrates of brain CYP2D
- (2013) Xiaoshuang Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metabolism and transport of tamoxifen in relation to its effectiveness: new perspectives on an ongoing controversy
- (2013) Deirdre P Cronin-Fenton et al. Future Oncology
- Interaction of Terbinafine (Anti-fungal agent) with Perhexiline: A Case Report
- (2013) Abdul Rauf Sheikh et al. Heart Lung and Circulation
- The impact of interacting drugs on dispensed doses of warfarin in the Swedish population: A novel use of population based drug registers
- (2013) M.L. Andersson et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Dynamics and persistence of CYP2D6 inhibition by paroxetine
- (2013) J. Juřica et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression
- (2013) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHIATRY
- Applications of CYP450 Testing in the Clinical Setting
- (2013) C. F. Samer et al. Molecular Diagnosis & Therapy
- A Randomized Trial of Genotype-Guided Dosing of Acenocoumarol and Phenprocoumon
- (2013) Talitha I. Verhoef et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing
- (2013) Stephen E. Kimmel et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized Trial of Genotype-Guided Dosing of Warfarin
- (2013) Munir Pirmohamed et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of CYP2C9 polymorphisms on the vulnerability to pharmacokinetic drug–drug interactions during acenocoumarol treatment
- (2013) Liliane Gschwind et al. PHARMACOGENOMICS
- Frequency and Outcomes of Concomitant Use of Proton Pump Inhibitors and Clopidogrel after Hospital Discharge
- (2013) Pedro Mas-Morey et al. THERAPIE
- Potential role of CYP2D6 in the central nervous system
- (2013) Jie Cheng et al. XENOBIOTICA
- The Discriminatory Value of CYP2D6 Genotyping in Predicting the Dextromethorphan/Dextrorphan Phenotype in Women with Breast Cancer
- (2012) Andreas Trojan et al. Breast Care
- The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
- (2012) F. L. Opdam et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- CYP2D6 phenotype indicative for optimized antiestrogen efficacy associates with outcome in early breast cancer patients
- (2012) Andreas Trojan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of Genetic Polymorphisms in CYP2C9 and CYP2C19 on the Pharmacokinetics of Clinically Used Drugs
- (2012) Takeshi Hirota et al. Drug Metabolism and Pharmacokinetics
- Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice
- (2012) J. Jurica et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned
- (2012) C. M. Kelly et al. JNCI-Journal of the National Cancer Institute
- Tamoxifen and CYP2D6: A Contradiction of Data
- (2012) D. L. Hertz et al. ONCOLOGIST
- Absence of ‘over-the-counter’ medicinal products in on-line prescription records: a risk factor of overlooking interactions in the elderly
- (2012) C. Olesen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation
- (2011) M. Schmidt et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
- (2011) Terry K. W. Ma et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis
- (2011) Pauline Lockhart et al. BRITISH JOURNAL OF GENERAL PRACTICE
- Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction
- (2011) Tabassome Simon et al. CIRCULATION
- Clinical Drugs Undergoing Polymorphic Metabolism by Human Cytochrome P450 2C9 and the Implication in Drug Development
- (2011) S.-M. He et al. CURRENT MEDICINAL CHEMISTRY
- Dextromethorphan As a Phenotyping Test to Predict Endoxifen Exposure in Patients on Tamoxifen Treatment
- (2011) Anne-Joy M. de Graan et al. JOURNAL OF CLINICAL ONCOLOGY
- High-risk antimicrobial prescriptions among ambulatory patients on warfarin
- (2011) M. A. Lane et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial
- (2011) T. Burkard et al. JOURNAL OF INTERNAL MEDICINE
- CYP2D6 Genotyping and Tamoxifen: An Unfinished Story in the Quest for Personalized Medicine
- (2011) Jonas A. de Souza et al. SEMINARS IN ONCOLOGY
- Cholesteryl ester transfer protein and its inhibition
- (2010) Olaf Weber et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Variability in drug metabolizing enzyme activity in HIV-infected patients
- (2010) Amanda E. Jones et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Herb–drug pharmacokinetic interactions reviewed
- (2010) Clemence Tarirai et al. Expert Opinion on Drug Metabolism & Toxicology
- Clopidogrel with or without Omeprazole in Coronary Artery Disease
- (2010) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response
- (2010) Kazuma Kiyotani et al. Pharmacogenetics and Genomics
- Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study
- (2010) Rolf P Kreutz et al. PHARMACOTHERAPY
- [13C]-pantoprazole breath test to predict CYP2C19 phenotype and efficacy of a proton pump inhibitor, lansoprazole
- (2009) T. FURUTA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Glucose Control by the Kidney: An Emerging Target in Diabetes
- (2009) Olivera Marsenic AMERICAN JOURNAL OF KIDNEY DISEASES
- The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients
- (2009) Milka Hauta-Aho et al. ANNALS OF MEDICINE
- Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in Healthy Volunteers
- (2009) SV Vormfelde et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Rapid Identification of the Hepatic Cytochrome P450 2C19 Activity Using a Novel and Noninvasive [13C]Pantoprazole Breath Test
- (2009) Z. Desta et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- The largest prospective warfarin-treated cohort supports genetic forecasting
- (2008) M. Wadelius et al. BLOOD
- CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype
- (2008) N A Helsby et al. BRITISH JOURNAL OF CANCER
- CYP2D6 Phenotype Prediction From Genotype: Which System Is the Best?
- (2008) J Kirchheiner CLINICAL PHARMACOLOGY & THERAPEUTICS
- Differential Genotype Dependent Inhibition of CYP2C9 in Humans
- (2008) V. Kumar et al. DRUG METABOLISM AND DISPOSITION
- Evaluation of a [13C]-Dextromethorphan Breath Test to Assess CYP2D6 Phenotype
- (2008) J. Steven Leeder et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Terbinafine-associated inhibition of dextromethorphan metabolism in Chinese subjects
- (2003) W. M. Cai et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started